What is Tesamorelin?
Research Focus: Metabolic, Liver, Weight Loss
Tesamorelin is a synthetic analog of Growth Hormone Releasing Hormone (GHRH). It is studied for its ability to stimulate the pituitary gland to release GH, specifically targeting visceral fat reduction.
At a Glance
Tesamorelin is a modified GHRH peptide that promotes the pulsatile release of GH. Its primary research focus is on reducing excess visceral adipose tissue (VAT), the fat stored deep within the abdomen. This section provides a general overview of its research context.
About Tesamorelin
Tesamorelin is a modified GHRH peptide that promotes the pulsatile release of GH. Its primary research focus is on reducing excess visceral adipose tissue (VAT), the fat stored deep within the abdomen.
How It Works
GH Release
Stimulates the pituitary gland to release endogenous GH.
Visceral Fat Lipolysis
The resulting GH increase preferentially targets the breakdown of visceral fat.
Metabolic Improvement
Leads to improved lipid profiles and reduced liver fat.
Current Research Insights
Targeted Fat Reduction
Tesamorelin is unique in research for its specific and effective targeting of visceral fat, which is strongly linked to cardiovascular risk.
Areas of Study
HIV-Associated Lipodystrophy
Investigated for reducing excess abdominal fat in HIV patients.
Non-Alcoholic Fatty Liver Disease (NAFLD)
Studied for reducing fat accumulation in the liver.
Cognitive Function
Researching its potential neuroprotective effects.
Tesamorelin is strictly intended for laboratory and clinical research:
- Available exclusively from authorized research suppliers
- Not FDA-approved for general therapeutic use
- Comprehensive safety, efficacy, and dosage guidelines remain under ongoing investigation
FAQs
Research
- Clinical trials on Tesamorelin for visceral fat reduction and metabolic improvement.
- Studies comparing Tesamorelin to other GHRH analogs.
(The above references are representative and support the research context of this peptide, GLP hormone or regenerative therapy. All claims are for research purposes only and do not imply approved medical use.)